MNPR (Monopar Therapeutics Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by MNPR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-28 | Raymond Anderson | Director | MIXED | — | — |
| 2026-08-28 | Kim R Tsuchimoto | Director | MIXED | — | — |
| 2026-08-27 | Raymond Anderson | Director | Sell | — | — |
| 2026-08-27 | PATRICE RIOUX | — | MIXED | — | — |
| 2026-08-27 | Kim R Tsuchimoto | Director | Sell | — | — |
| 2026-07-02 | Quan Anh Vu | Chief Financial Officer | MIXED | — | — |
| 2026-07-02 | Andrew Cittadine | Chief Operating Officer | MIXED | — | — |
| 2026-07-02 | Chandler Robinson | Chief Executive Officer | MIXED | — | — |
| 2026-04-02 | Andrew Cittadine | Chief Operating Officer | MIXED | — | — |
| 2026-04-02 | Chandler Robinson | Chief Executive Officer | MIXED | — | — |
| 2026-03-04 | Susan Rodriguez | CCSO | A | — | — |
| 2026-01-30 | Chandler Robinson | Chief Executive Officer | J | — | — |
| 2026-01-05 | PATRICE RIOUX | — | A | — | — |
| 2026-01-05 | Chandler Robinson | Chief Executive Officer | MIXED | — | — |
| 2026-01-05 | Andrew Cittadine | Chief Operating Officer | MIXED | — | — |
| 2025-12-29 | Quan Anh Vu | Chief Financial Officer | Buy | — | — |
| 2025-12-19 | ARTHUR J KLAUSNER | Director | Sell | — | — |
| 2025-12-17 | ARTHUR J KLAUSNER | Director | J | — | — |
| 2025-12-17 | Diane Hendricks | 10%+ Owner | J | — | — |
| 2025-12-08 | Kim R Tsuchimoto | Director | A | — | — |
| 2025-12-08 | ARTHUR J KLAUSNER | Director | A | — | — |
| 2025-12-08 | CHRISTOPHER M STARR | Director | A | — | — |
| 2025-12-08 | Chandler Robinson | Chief Executive Officer | A | — | — |
| 2025-12-08 | Raymond Anderson | Director | A | — | — |
| 2025-12-08 | Lavina Talukdar | Director | A | — | — |
| 2025-12-08 | Quan Anh Vu | Chief Financial Officer | A | — | — |
| 2025-12-08 | Andrew Cittadine | Chief Operating Officer | A | — | — |
| 2025-10-02 | Chandler Robinson | Chief Executive Officer | MIXED | — | — |
| 2025-10-02 | Andrew Cittadine | Chief Operating Officer | MIXED | — | — |
| 2025-09-26 | Andrew Paul Mazar | — | Sell | — | — |
| 2025-07-16 | Kim R Tsuchimoto | Director | MIXED | — | — |
| 2025-07-16 | Chandler Robinson | Chief Executive Officer | MIXED | — | — |
| 2025-07-16 | CHRISTOPHER M STARR | Director | MIXED | — | — |
| 2025-07-02 | Andrew Cittadine | Chief Operating Officer | MIXED | — | — |
| 2025-07-02 | Chandler Robinson | Chief Executive Officer | MIXED | — | — |
| 2025-04-04 | Thomas V. O'Halloran | — | Sell | — | — |
| 2025-04-02 | Chandler Robinson | Chief Executive Officer | MIXED | — | — |
| 2025-04-02 | Andrew Cittadine | Chief Operating Officer | MIXED | — | — |
| 2025-03-07 | Kim R Tsuchimoto | Director | A | — | — |
| 2025-03-07 | ARTHUR J KLAUSNER | Director | A | — | — |
| 2025-03-07 | CHRISTOPHER M STARR | Director | A | — | — |
| 2025-03-07 | Raymond Anderson | Director | A | — | — |
| 2025-03-07 | Lavina Talukdar | Director | A | — | — |
| 2025-03-07 | Chandler Robinson | Chief Executive Officer | MIXED | — | — |
| 2025-03-07 | Andrew Cittadine | Chief Operating Officer | A | — | — |
| 2025-03-05 | Quan Anh Vu | Chief Financial Officer | A | — | — |
| 2025-01-02 | PATRICE RIOUX | — | A | — | — |
| 2025-01-02 | Chandler Robinson | Chief Executive Officer | MIXED | — | — |
| 2025-01-02 | Andrew Cittadine | Chief Operating Officer | MIXED | — | — |
| 2024-12-17 | TacticGem LLC | 10%+ Owner | J | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | — | 822,255 | — |
| — | Director | 620,302 | — |
| — | Chief Scientific Officer | 305,359 | — |
| — | Chief Executive Officer | 162,082 | — |
| — | 10%+ Owner | 93,750 | — |
| — | Director | 80,506 | — |
| — | Chief Operating Officer | 55,614 | — |
| — | 10%+ Owner | 31,313 | — |
| — | Director | 15,053 | — |
| — | Director | 14,476 | — |
| — | Director | 6,775 | — |
| — | — | 5,065 | — |
| — | Chief Financial Officer | 2,221 | — |
| — | Chief Financial Officer | 1,550 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MNPR quote page; the site-wide leaderboard is on the insider transactions hub.